Ads
related to: mrnaWe Provide a Diverse Portfolio of Premium Products to Aid in Your Research. Complete Portfolio of Premium Products to Assist in Your Research.
- Analytical/Chromatography
Browse our Analytical Reagents,
Standards, Microbiology and more.
- Sigma® Life Science
Cell culture, antibodies
and more biological products
- Order Center
Build a Shopping Cart, View Orders
Access ordering instructions
- Classic Lab Chemicals
High-quality laboratory reagents.
Solvents, salts, acids, bases
- Sign In
Sigma® Life Science
View contract pricing, get quotes
- Register an Account
Get product updates, special offers
Save favorites & shopping lists
- Analytical/Chromatography
VectorBuilder offers large scale mRNA manufacturing and Lipid NanoParticle encapsulation. In vitro/in vivo functional testing to accelerate the development of mRNA.
Search results
7 hours ago · Below is Validea's guru fundamental report for MODERNA INC ().Of the 22 guru strategies we follow, MRNA rates highest using our Value Investor model based on the published strategy of Benjamin Graham.
19 hours ago · HanAll Biopharma, a Korean biotech company, said it signed an exclusive licensing agreement with Turn Biotechnologies, a U.S. cell reprogramming biotech firm. Turn Biotechnologies specializes in cell reprogramming technologies aimed at reversing the biological clock of cells. The company is conducti
19 hours ago · 한올바이오파마가 ‘턴바이오(Turn Biotechnologies)’와 독점적 기술 도입 계약을 체결하며 mRNA 플랫폼의 오픈 콜라보레이션을 통해 역노화치료제 개발에 본격 나선다고 27일 밝혔다.턴바이오는 세포의 생체 시계를 되돌리는 ‘세포 리프로그래밍’ 기술을 연구하는 바이오 신약 기업으로 현재 피부과 ...
May 28, 2024 · 随着公司的新冠 mRNA 疫苗取得阶段性成果，技术平台进一步获得验证。在未来的研发过程中，公司会坚持快中求稳，以期实现公司的可持续发展，关于公司新产品的研发进展请以公司披露的公告为准。谢谢！
News about Moderna Inc, GF Score, mRNA-4157
News about blood, Barbados, mRNA
Also in the news
19 hours ago · AMA Style. Li S, Yang Q, Li M, Lan Y, Song Z. Integrated miRNA and mRNA Sequencing Reveals the Sterility Mechanism in Hybrid Yellow Catfish Resulting from Pelteobagrus fulvidraco (♀) × Pelteobagrus vachelli (♂).
19 hours ago · 한올바이오파마(HanAll Biopharma)가 세포 리프로그래밍(reprogramming) 신약 개발사 턴바이오테크놀로지(Turn Biotechnologies)와 독점적 기술도입(L/I) 계약을 체결하며 mRNA로의 치료 영역을 확대한다. 한올바이오파마는 27일 턴바이오와 ...
19 hours ago · 한올바이오파마 정승원 대표는 “이번 기술도입을 계기로 mrna 치료제로의 r&d 역량을 강화해 나가며 파이프라인 확장 가능성을 지속적으로 모색해 ...
Ad
related to: mrnaWe Provide a Diverse Portfolio of Premium Products to Aid in Your Research. Complete Portfolio of Premium Products to Assist in Your Research.
